COVID Solidarity Response getting Aon's vax-protection revenue

As of May 2021, the fund has deployed more than $250 million to support WHO’s worldwide efforts in fighting COVID.

Aon CEO Greg Case: “By benefitting the COVID-19 Solidarity Response Fund, our new collaborative solution is not only providing first-hand support in supply chain management but also aiding other critical life-saving efforts of the WHO Foundation.” (Credit: BaLL LunLa/Shutterstock.com)

Aon plc is donating 100% of the revenue from its COVID-19 vaccination supply chain protection program to the COVID-19 Solidarity Response Fund, the company reported.

“As we continue to move toward the ‘New Better’ and have seen incredible progress in some areas when it comes to vaccine distribution, the COVID-19 pandemic is still affecting communities around the world in unprecedented ways, and its impact will continue to reverberate for years to come,” Greg Case, Aon CEO, said in a release. “By benefitting the COVID-19 Solidarity Response Fund, our new collaborative solution is not only providing first-hand support in supply chain management but also aiding other critical life-saving efforts of the WHO Foundation.”

The fund was set up to support the World Health Organization (WHO) and is the only way for an individual or organization to directly support the global efforts of WHO and its partners, Aon reported.

The supply chain protection program is comprised of a broader coalition of insurance players and companies from adjacent industries. It leverages sensor data and analytics to manage risks more effectively while mitigating potential losses of the medicine. Qualified parties in the vaccine supply chain are eligible, including pharmaceutical firms, government bodies, transportation and logistics companies, distributors, health systems, pharmacy chains and inoculation centers, Aon said.

As of May 2021, the fund has deployed more than $250 million to support WHO’s global efforts to suppress remission of the virus, reduce mortality, protect the vulnerable and accelerate access to emerging COVID-19 tools.

“Navigating vaccine distribution at a global scale is one of the most immediate and pressing hurdles facing our leaders today,” Paul Kim, head of strategy and product development, commercial risk solutions at Aon, said in a statement. “It is an honor to support the WHO Foundation to maximize the impact of our efforts. We are proud to not only provide an innovative offering to help work toward equitable global distribution but to also directly benefit a fund that is impacting communities around the world in the fight against COVID-19.”

Related: